2016
DOI: 10.1080/14760584.2016.1182024
|View full text |Cite
|
Sign up to set email alerts
|

Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines

Abstract: Summary Several arenaviruses, chiefly Lassa virus (LASV), cause hemorrhagic fever (HF) disease in humans and pose significant public health problems in their endemic regions. Moreover, HF arenaviruses represent credible biodefense threats. There are not FDA-approved arenavirus vaccines and current anti-arenaviral therapy is limited to an off-label use of ribavirin that is only partially effective. Live-attenuated vaccines (LAV) represent the most feasible approach to control HF arenaviruses within their endemi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 60 publications
0
2
0
Order By: Relevance
“…Lymphocytic choriomeningitis virus (LCMV), a model for arenavirus biology and mapping of the cellular immune responses, is globally seroprevalent and responsible for febrile illness, aseptic meningitis, neonatal disease, and multiple organ failure in transplant patients ( 3 9 ). Although promising vaccine candidates ( 10 13 ) and therapeutic treatments ( 14 16 ) have been developed to combat arenavirus diseases, to date there are limited effective intervention strategies for infected individuals.…”
Section: Introductionmentioning
confidence: 99%
“…Lymphocytic choriomeningitis virus (LCMV), a model for arenavirus biology and mapping of the cellular immune responses, is globally seroprevalent and responsible for febrile illness, aseptic meningitis, neonatal disease, and multiple organ failure in transplant patients ( 3 9 ). Although promising vaccine candidates ( 10 13 ) and therapeutic treatments ( 14 16 ) have been developed to combat arenavirus diseases, to date there are limited effective intervention strategies for infected individuals.…”
Section: Introductionmentioning
confidence: 99%
“…The L segment codes for the RNA-dependent RNA polymerase (L) and the small matrix protein (Z), while the S segment encodes the nucleocapsid protein (N) and a glycoprotein precursor (GPC). Some members of this family cause hemorrhagic fever disease in humans and represent an important public health concern in their endemic regions, such as Lassa and Lujo viruses in Africa, Sabiá virus in Brazil, Guanarito virus in Venezuela, Chaparé and Machupo viruses (MACV) in Bolivia, and Junín virus (JUNV) in Argentina [ 1 , 2 ]. JUNV is the etiological agent of Argentine hemorrhagic fever (AHF), with the administration of immune plasma being the only therapeutic intervention against the disease.…”
Section: Introductionmentioning
confidence: 99%